Suppr超能文献

人小梁骨来源的成骨细胞在特定的无血清培养基中可在体外支持人破骨细胞的形成。

Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.

作者信息

Atkins Gerald J, Kostakis Panagiota, Welldon Katie J, Vincent Cristina, Findlay David M, Zannettino Andrew C W

机构信息

Department of Orthopaedics and Trauma, University of Adelaide, and the Hanson Institute, Adelaide, South Australia, Australia.

出版信息

J Cell Physiol. 2005 Jun;203(3):573-82. doi: 10.1002/jcp.20255.

Abstract

While it has been assumed that osteoblasts in the human support osteoclast formation, in vitro evidence of this is currently lacking. We tested the ability of normal human trabecular bone-derived osteoblasts (NHBCs) to support osteoclast formation from human peripheral blood mononuclear cells (PBMC) in response to treatment with either 1alpha,25-dihydroxyvitamin D3 (1,25D) or parathyroid hormone (PTH), using a serum-replete medium previously used to support human osteoclast formation on a stroma of murine ST-2 cells. Under these conditions, NHBC did not support osteoclast formation, as assessed by morphological, histochemical, and functional criteria, despite our previous results demonstrating a link between induction of RANKL mRNA expression and NHBC phenotype in these media. We next tested a defined, serum-free medium (SDM) on NHBC phenotype, their expression of RANKL and OPG, and their ability to support osteoclast formation. SDM, containing dexamethasone (DEX) and 1,25D, induced phenotypic maturation of NHBC, based on the expression of STRO-1 and the bone/liver/kidney isoform of alkaline phosphatase (AP). PTH as a single factor did not induce phenotypic change. 1,25D and DEX induced the greatest ratio of RANKL:OPG mRNA, predictive of supporting osteoclast formation. Consistent with this, co-culture of NHBC with CD14+ PBMC, or bone marrow mononuclear cell (BMMC), or CD34+ BMMC precursors in SDM + 1,25D + DEX, resulted in functional osteoclast formation. Osteoclast formation also occurred in PTH + DEX stimulated co-cultures. Interestingly, SDM supplemented with recombinant RANKL (25-100 ng/ml) and M-CSF (25 ng/ml), did not induce osteoclast formation from any of the osteoclast precursor populations in stromal-free cultures, unlike serum-replete medium. This study demonstrates that under the appropriate conditions, adult human primary osteoblasts can support de novo osteoclast formation, and this model will enable the detailed study of the role of both cell types in this process.

摘要

虽然一直认为人类成骨细胞能支持破骨细胞形成,但目前缺乏这方面的体外证据。我们使用一种先前用于支持人类破骨细胞在小鼠ST-2细胞基质上形成的富含血清的培养基,测试了正常人小梁骨来源的成骨细胞(NHBCs)在1α,25-二羟基维生素D3(1,25D)或甲状旁腺激素(PTH)处理下支持人外周血单核细胞(PBMC)形成破骨细胞的能力。在这些条件下,尽管我们之前的结果表明在这些培养基中RANKL mRNA表达的诱导与NHBC表型之间存在联系,但通过形态学、组织化学和功能标准评估,NHBC不支持破骨细胞形成。接下来,我们在NHBC表型、它们的RANKL和OPG表达以及它们支持破骨细胞形成的能力方面测试了一种确定的无血清培养基(SDM)。基于STRO-1和碱性磷酸酶(AP)的骨/肝/肾同工型的表达,含有地塞米松(DEX)和1,25D的SDM诱导了NHBC的表型成熟。单独的PTH因子不诱导表型变化。1,25D和DEX诱导了最大的RANKL:OPG mRNA比值,预示着支持破骨细胞形成。与此一致的是,在SDM + 1,25D + DEX中,NHBC与CD14 + PBMC、或骨髓单核细胞(BMMC)、或CD34 + BMMC前体共培养,导致功能性破骨细胞形成。在PTH + DEX刺激下的共培养中也发生了破骨细胞形成。有趣的是,与富含血清的培养基不同,补充重组RANKL(25 - 100 ng/ml)和M-CSF(25 ng/ml)的SDM在无基质培养中不能从任何破骨细胞前体群体诱导破骨细胞形成。这项研究表明,在适当条件下,成人原代成骨细胞可以支持破骨细胞的从头形成,并且这个模型将能够详细研究这两种细胞类型在此过程中的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验